LHC Group Stock Price, News & Analysis (NASDAQ:LHCG)

LHC Group trades on the NASDAQ under the ticker symbol "LHCG."

LHC Group, Inc. (NASDAQ:LHCG) issued its quarterly earnings results on Wednesday, August, 7th. The health services provider reported $1.07 EPS for the quarter, beating the Zacks' consensus estimate of $1.01 by $0.06. The health services provider had revenue of $517.84 million for the quarter, compared to analysts' expectations of $524.24 million. LHC Group had a net margin of 4.20% and a return on equity of 8.83%. The business's quarterly revenue was up 3.2% compared to the same quarter last year. During the same quarter in the prior year, the firm posted $0.84 earnings per share. View LHC Group's Earnings History.

LHC Group is scheduled to release their next quarterly earnings announcement on Wednesday, October 30th 2019. View Earnings Estimates for LHC Group.

LHC Group updated its FY19 earnings guidance on Wednesday, August, 7th. The company provided earnings per share guidance of $4.25 to $4.35 for the period, compared to the Thomson Reuters consensus estimate of $4.31. The company issued revenue guidance of $2.09-2.14 billion, compared to the consensus revenue estimate of $2.11 billion.

10 brokers have issued twelve-month price objectives for LHC Group's stock. Their forecasts range from $114.00 to $146.00. On average, they anticipate LHC Group's share price to reach $130.67 in the next twelve months. This suggests a possible upside of 15.3% from the stock's current price. View Analyst Price Targets for LHC Group.

10 Wall Street analysts have issued "buy," "hold," and "sell" ratings for LHC Group in the last year. There are currently 3 hold ratings and 7 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for LHC Group.

News coverage about LHCG stock has been trending positive recently, InfoTrie Sentiment reports. The research group identifies negative and positive press coverage by reviewing more than six thousand blog and news sources in real time. The firm ranks coverage of publicly-traded companies on a scale of negative five to five, with scores closest to five being the most favorable. LHC Group earned a media sentiment score of 2.1 on InfoTrie's scale. They also assigned headlines about the health services provider a news buzz of 0.0 out of 10, indicating that recent press coverage is extremely unlikely to have an impact on the company's share price in the near term. View News Stories for LHC Group.

LHC Group saw a decrease in short interest in the month of September. As of September 30th, there was short interest totalling 1,860,000 shares, a decrease of 7.0% from the August 30th total of 2,000,000 shares. Based on an average daily volume of 220,100 shares, the short-interest ratio is presently 8.5 days. Approximately 6.3% of the company's stock are short sold. View LHC Group's Current Options Chain.

Some companies that are related to LHC Group include Chemed (CHE), Amedisys (AMED), Addus Homecare (ADUS), Civitas Solutions (CIVI), BioScrip (BIOS) and New York Health Care (BBAL).

Based on aggregate information from My MarketBeat watchlists, some companies that other LHC Group investors own include Home Depot (HD), Visa (V), Cisco Systems (CSCO), Chevron (CVX), Verizon Communications (VZ), Johnson & Johnson (JNJ), Alibaba Group (BABA), CVS Health (CVS), Exxon Mobil (XOM) and Intel (INTC).

LHC Group's stock is owned by a number of of retail and institutional investors. Top institutional shareholders include Tributary Capital Management LLC (0.88%), Copper Rock Capital Partners LLC (0.48%), Scout Investments Inc. (0.29%), State of Alaska Department of Revenue (0.07%) and Redhawk Wealth Advisors Inc. (0.01%). Company insiders that own LHC Group stock include Donald Dwayne Stelly, Jeff Reibel, John L Indest, Joshua L Proffitt, Keith G Myers, Ronald T Nixon and Tyree G Wilburn. View Institutional Ownership Trends for LHC Group.

LHCG stock was sold by a variety of institutional investors in the last quarter, including Tributary Capital Management LLC and Scout Investments Inc.. Company insiders that have sold LHC Group company stock in the last year include Donald Dwayne Stelly, Jeff Reibel, John L Indest, Joshua L Proffitt, Keith G Myers, Ronald T Nixon and Tyree G Wilburn. View Insider Buying and Selling for LHC Group.

LHCG stock was purchased by a variety of institutional investors in the last quarter, including Copper Rock Capital Partners LLC, State of Alaska Department of Revenue and Redhawk Wealth Advisors Inc.. View Insider Buying and Selling for LHC Group.

Shares of LHCG can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

One share of LHCG stock can currently be purchased for approximately $113.36.

LHC Group has a market capitalization of $3.57 billion and generates $1.81 billion in revenue each year. The health services provider earns $63.57 million in net income (profit) each year or $3.55 on an earnings per share basis. LHC Group employs 30,985 workers across the globe.View Additional Information About LHC Group.

The official website for LHC Group is http://www.lhcgroup.com/.

LHC Group's mailing address is 901 HUGH WALLIS ROAD SOUTH, LAFAYETTE LA, 70508. The health services provider can be reached via phone at 337-233-1307 or via email at [email protected]